Advertisement
Screener

ProQR Therapeutics N.V. (PRQR) Weighted Average Shares

2.8 / 5 stars · 68/120 Roast Me

ProQR Therapeutics N.V. Weighted Average Shares

ProQR Therapeutics N.V. (PRQR) reported Weighted Average Shares of 105.33 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.

Financial Statements › Income Statement › Earnings Per Share

ifrs-full:WeightedAverageShares · last filed 2026-03-12

  • ProQR Therapeutics N.V. weighted average shares for the quarter ending 2025-09-30 was 105.34M shares, a 28.97% increase year-over-year.
  • ProQR Therapeutics N.V. weighted average shares for the quarter ending 2025-06-30 was 105.34M shares, a 28.99% increase year-over-year.
  • ProQR Therapeutics N.V. weighted average shares for the quarter ending 2025-03-31 was 105.30M shares, a 29.09% increase year-over-year.
  • ProQR Therapeutics N.V. weighted average shares for the quarter ending 2024-09-30 was 81.68M shares, a 0.84% increase year-over-year.
Period endWeighted Average Shares 3 monthWeighted Average Shares 6 monthWeighted Average Shares 9 monthWeighted Average Shares 12 month
2025-12-31105.33M shares
20-F · filed 2026-03-12
2025-09-30105.34M shares
6-K · filed 2025-11-06
105.33M shares
6-K · filed 2025-11-06
2025-06-30105.34M shares
6-K · filed 2025-08-07
105.32M shares
6-K · filed 2025-08-07
2025-03-31105.30M shares
6-K · filed 2025-05-08
2024-12-3186.09M shares
20-F · filed 2026-03-12
2024-09-3081.68M shares
6-K · filed 2025-11-06
81.64M shares
6-K · filed 2025-11-06
2024-06-3081.67M shares
6-K · filed 2025-08-07
81.62M shares
6-K · filed 2025-08-07
2024-03-3181.57M shares
6-K · filed 2025-05-08
2023-12-3181.01M shares
20-F · filed 2026-03-12
2023-09-3081.00M shares
6-K · filed 2024-11-07
80.94M shares
6-K · filed 2024-11-07
2023-06-3080.94M shares
6-K · filed 2024-08-08
80.91M shares
6-K · filed 2024-08-08
2023-03-3180.89M shares
6-K · filed 2024-05-09
2022-12-3171.64M shares
20-F · filed 2025-03-13
2022-09-3071.38M shares
6-K · filed 2023-11-07
71.37M shares
6-K · filed 2023-11-07
2022-06-3071.36M shares
6-K · filed 2023-08-03
71.36M shares
6-K · filed 2023-08-03
2022-03-3171.36M shares
6-K · filed 2023-05-16
2021-12-3171.24M shares
6-K · filed 2022-02-24
64.18M shares
20-F · filed 2024-03-13
2021-09-3068.26M shares
6-K · filed 2022-11-09
61.80M shares
6-K · filed 2022-11-09
2021-06-3066.15M shares
6-K · filed 2022-08-04
58.52M shares
6-K · filed 2022-08-04
2021-03-3150.81M shares
6-K · filed 2022-05-05
2020-12-3150.17M shares
6-K · filed 2022-02-24
50.06M shares
20-F · filed 2023-03-29
2020-09-3050.14M shares
6-K · filed 2021-11-04
50.02M shares
6-K · filed 2021-11-04
2020-06-3050.02M shares
6-K · filed 2021-08-05
49.96M shares
6-K · filed 2021-08-05
2020-03-3149.91M shares
6-K · filed 2020-05-07
2019-12-3147.37M shares
6-K · filed 2021-02-25
41.04M shares
20-F · filed 2022-04-29
2019-09-3038.91M shares
6-K · filed 2020-11-16
38.90M shares
6-K · filed 2020-11-16
2019-06-3038.91M shares
6-K · filed 2020-08-06
38.90M shares
6-K · filed 2020-08-06
2019-03-3138.89M shares
6-K · filed 2020-05-07
2018-12-3134.05M shares
20-F · filed 2021-03-24
2018-09-3033.36M shares
6-K · filed 2019-11-12
32.44M shares
6-K · filed 2019-11-12
2018-06-3031.93M shares
6-K · filed 2019-08-07
31.92M shares
6-K · filed 2019-08-07
2017-12-3125.37M shares
20-F · filed 2020-03-31
2017-06-3023.99M shares
6-K · filed 2018-08-08
23.73M shares
6-K · filed 2018-08-08
2016-12-3123.35M shares
20-F · filed 2019-03-28
2015-12-3123.34M shares
20-F · filed 2018-03-30